東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Linked to FindBook

Google Book

Amazon

博客來

Public-private-partnerships in drug research and development

Record Type:	Electronic resources : Monograph/item
Title/Author:	Public-private-partnerships in drug research and development/ edited by Martin C. Michel, Heike A. Wieland.
other author:	Michel, Martin C.
Published:	Cham :Springer Nature Switzerland : : 2024.,
Description:	xi, 196 p. :ill. (some col.), digital ;24 cm.
[NT 15003449]:	Novel and proven models of Public Private and Public Private Partnerships in Healthcare An Update -- Project based Public private collaborations -- Collaborative Innovations in Childhood Cancer Therapies -- Reaching outer space and enabling the mRNA revolution a critical role of partnerships for successful drug and vaccine development -- The Alliance between the German Cancer Research Center and Bayer a retrospective of an innovative collaboration model -- Life Science Incubation at LabCentral BioLabs with Partners Extending from the US to Europe -- Innovation at the Interface between Academia and Industry The BioMed X Model -- From innovator result driven to multi actor impact oriented Public Private Partnerships Integrating the patient perspective -- The Legal Framework for PPP in Drug R&D.
Contained By:	Springer Nature eBook
Subject:	Drug development. -
Online resource:	https://doi.org/10.1007/978-3-031-75806-5
ISBN:	9783031758065

Public-private-partnerships in drug research and development
Public-private-partnerships in drug research and development[electronic resource] /edited by Martin C. Michel, Heike A. Wieland. - Cham :Springer Nature Switzerland :2024. - xi, 196 p. :ill. (some col.), digital ;24 cm. - Handbook of experimental pharmacology,v. 2861865-0325 ;. - Handbook of experimental pharmacology ;v. 286..

Novel and proven models of Public Private and Public Private Partnerships in Healthcare An Update -- Project based Public private collaborations -- Collaborative Innovations in Childhood Cancer Therapies -- Reaching outer space and enabling the mRNA revolution a critical role of partnerships for successful drug and vaccine development -- The Alliance between the German Cancer Research Center and Bayer a retrospective of an innovative collaboration model -- Life Science Incubation at LabCentral BioLabs with Partners Extending from the US to Europe -- Innovation at the Interface between Academia and Industry The BioMed X Model -- From innovator result driven to multi actor impact oriented Public Private Partnerships Integrating the patient perspective -- The Legal Framework for PPP in Drug R&D.

Collaborative approaches are becoming a key driver in drug discovery and development. They come in many types and forms ranging from project-based collaborations and strategic alliances to large international consortia. The volume discusses various types of such collaboration including the specific uses, advantages, and challenges. Based on the nature of public-private partnerships, we present views and experiences from academia, industry, and public stakeholders.

ISBN: 9783031758065

Standard No.: 10.1007/978-3-031-75806-5doiSubjects--Topical Terms:

716904
Drug development.

LC Class. No.: RM301.25

Dewey Class. No.: 615.19

Public-private-partnerships in drug research and development
LDR:02367nmm a2200337 a 4500 001 2380708
003 DE-He213
005 20241121115230.0
006 m d
007 cr nn 008maaau
008 250418s2024 sz s 0 eng d
020 $a 9783031758065 $q (electronic bk.)
020 $a 9783031758058 $q (paper)
024 7 $a 10.1007/978-3-031-75806-5 $2 doi
035 $a 978-3-031-75806-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.25
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615.19 $2 23
090 $a RM301.25 $b .P976 2024
245 0 0 $a Public-private-partnerships in drug research and development $h [electronic resource] / $c edited by Martin C. Michel, Heike A. Wieland.
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2024.
300 $a xi, 196 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 1865-0325 ; $v v. 286
505 0 $a Novel and proven models of Public Private and Public Private Partnerships in Healthcare An Update -- Project based Public private collaborations -- Collaborative Innovations in Childhood Cancer Therapies -- Reaching outer space and enabling the mRNA revolution a critical role of partnerships for successful drug and vaccine development -- The Alliance between the German Cancer Research Center and Bayer a retrospective of an innovative collaboration model -- Life Science Incubation at LabCentral BioLabs with Partners Extending from the US to Europe -- Innovation at the Interface between Academia and Industry The BioMed X Model -- From innovator result driven to multi actor impact oriented Public Private Partnerships Integrating the patient perspective -- The Legal Framework for PPP in Drug R&D.
520 $a Collaborative approaches are becoming a key driver in drug discovery and development. They come in many types and forms ranging from project-based collaborations and strategic alliances to large international consortia. The volume discusses various types of such collaboration including the specific uses, advantages, and challenges. Based on the nature of public-private partnerships, we present views and experiences from academia, industry, and public stakeholders.
650 0 $a Drug development. $3 716904
650 0 $a Drugs $x Research. $3 685164
650 0 $a Public-private sector cooperation. $3 564004
650 0 $a Research and development partnership. $3 2063968
650 1 4 $a Pharmacology. $3 634543
650 2 4 $a Biomedical Research. $3 851895
700 1 $a Michel, Martin C. $3 1532569
700 1 $a Wieland, Heike A. $3 3734332
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Handbook of experimental pharmacology ; $v v. 286. $3 3734333
856 4 0 $u https://doi.org/10.1007/978-3-031-75806-5
950 $a Biomedical and Life Sciences (SpringerNature-11642)